Health Technology · Pharmaceuticals: Major · NSE: LAURUSLABS · data 2026-10-09
Laurus Labs Ltd.
Health check: Average (5.9/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹2,036.6
Market cap
₹1,08,062 cr
P/E
100.7
P/B
—
ROE
18.2%
ROCE
20.5%
Debt / equity
0.48
Dividend yield
0.10%
1-year return
136.5%
52-week high
₹2,065.2
52-week low
₹864.7
Operating margin
21.3%
Growth
| Revenue (last 12 months) | ₹7,270 cr |
| Net profit (last 12 months) | ₹1,093 cr |
| Sales growth, 3 years (yearly) | 4.1% |
| Profit growth, 3 years (yearly) | 4.0% |
Similar companies
Torrent Pharmaceuticals Ltd (TORNTPHARM) · Zydus Lifesciences Limited (ZYDUSLIFE) · Mankind Pharma Ltd. (MANKIND) · Dr. Reddy's Laboratories Ltd. (DRREDDY) · Alkem Laboratories Ltd. (ALKEM)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open LAURUSLABS in NSE Scanner →